| 注册
首页|期刊导航|眼科新进展|近视性黄斑劈裂治疗方法最新研究进展

近视性黄斑劈裂治疗方法最新研究进展

席成敏 吕洋

眼科新进展2025,Vol.45Issue(6):495-499,5.
眼科新进展2025,Vol.45Issue(6):495-499,5.DOI:10.13389/j.cnki.rao.2025.0087

近视性黄斑劈裂治疗方法最新研究进展

Recent research advances in the treatment of myopic foveoschisis

席成敏 1吕洋2

作者信息

  • 1. 730050 甘肃省兰州市,中国人民解放军联勤保障部队第九四○医院眼科中心||730000 甘肃省兰州市,甘肃中医药大学第一临床医学院||730050 甘肃省兰州市,中国人民解放军联勤保障部队第九四○医院基础医学实验室,甘肃省干细胞与基因药物重点实验室
  • 2. 730050 甘肃省兰州市,中国人民解放军联勤保障部队第九四○医院眼科中心
  • 折叠

摘要

Abstract

In recent years,myopic foveoschisis(MF)has become a common complication in individuals with high my-opia,mainly due to the combination of the inward traction of vitreoretinal adhesions and the outward traction exerted on the retina by posterior scleral staphyloma.As one of the common complications of pathological myopia,MF seriously af-fects the vision of patients.The main surgical procedures for highly myopic patients with MF include vitrectomy,macular buckle,and posterior scleral reinforcement.However,there are still controversies about the need for internal limiting membrane peeling and gas tamponade.In addition to surgical treatment,drug treatment is also under continuous explora-tion.A variety of drugs have been used to improve visual function through different mechanisms.This paper summarizes the current treatment methods for patients with MF,in an attempt to provide reference for researchers.

关键词

近视/黄斑劈裂/抗血管内皮生长因子药物/玻璃体切割术/黄斑扣带术

Key words

myopia/myopic foveoschisis/anti-vascular endothelial growth factor drugs/vitreoretinal surgery/macu-lar buckle

分类

医药卫生

引用本文复制引用

席成敏,吕洋..近视性黄斑劈裂治疗方法最新研究进展[J].眼科新进展,2025,45(6):495-499,5.

基金项目

国家自然科学基金(编号:82000926) (编号:82000926)

甘肃省卫生健康委员会基金项目(编号:GSWSKY2022-05) (编号:GSWSKY2022-05)

甘肃省自然科学基金项目(编号:24JRRA003) (编号:24JRRA003)

联勤保障部队第九四○医院院基金(编号:2021yxky033,2023YXKY011,2023YXKY033) (编号:2021yxky033,2023YXKY011,2023YXKY033)

军队课题(编号:24BJZ41,2024-G2-4) (编号:24BJZ41,2024-G2-4)

兰州市课题(编号:2024-9-126) (编号:2024-9-126)

眼科新进展

OA北大核心

1003-5141

访问量0
|
下载量0
段落导航相关论文